NCT06404164Recruiting
Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
Artificial Intelligence Pulmonary Watershed Terrain Navigation System for Lung Nodule Localization and Lung Function Preservation
Source: ClinicalTrials.gov · Last updated 8 May 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
A method of ICG counterstaining localization under target artery occlusion without cutting，It's a new method of localization of small pulmonary nodules.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 3000 (estimated)
- First submitted
- 27 Apr 2024
- Start date
- 30 Jan 2022
- Primary completion date
- 3 Apr 2024
- Lead sponsor
- Guangdong Provincial People's Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06404164
What you commit to
- Study type: Interventional
- Planned participants: 3000
- From 30 Jan 2022 to the primary completion date, 3 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No surgical video, no postoperative gross specimen and related distance measurement records
- The resection range exceeds 50% of the preoperative planning
- Any situation where the investigator feels the need for extended resection
Other illness
- Patients with chronic diseases (such as COPD, pulmonary fibrosis, silicosis) that can cause loss of lung function in patients at risk of progression or potential progression
Other
- The incision edge does not exceed the target nodule diameter from the nodule edge
- Postoperative pathological staging non-pT1aN0M0 IA1 stage/pT1bN0M0 IA2 stage (eighth edition)
Who the study is looking for
- \<1cm CTR≤0.75; \<1.5cm CTR≤0.5; \<2cm CTR≤0.25 Lung nodules
- The tumor center is located in the peripheral 2/3 area of the lung field
- Preoperative analysis and planning of watershed by 3D reconstruction
- Clinically assessed as cT1aN0M0 stage IA1/cT1bN0M0 stage IA2 (eighth edition), clinically resectable
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Guangdong Provincial People's Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.